Serum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure

Abstract Iron is an essential trace element in the body. However, in heart failure (HF), iron is only recognized as the cause of anemia. Actually, iron itself affects myocardial exercise tolerance and cardiac function via mitochondrial function. Therefore, it is necessary to clarify the pathological...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tomoya Ueda, Rika Kawakami, Kazutaka Nogi, Maki Nogi, Satomi Ishihara, Yasuki Nakada, Tomoya Nakano, Yukihiro Hashimoto, Hitoshi Nakagawa, Taku Nishida, Kenji Onoue, Tsunenari Soeda, Satoshi Okayama, Makoto Watanabe, Yoshihiko Saito
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8d103a2884c24708ac5c30d0291e5d99
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8d103a2884c24708ac5c30d0291e5d99
record_format dspace
spelling oai:doaj.org-article:8d103a2884c24708ac5c30d0291e5d992021-12-02T13:57:59ZSerum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure10.1038/s41598-021-82063-02045-2322https://doaj.org/article/8d103a2884c24708ac5c30d0291e5d992021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-82063-0https://doaj.org/toc/2045-2322Abstract Iron is an essential trace element in the body. However, in heart failure (HF), iron is only recognized as the cause of anemia. Actually, iron itself affects myocardial exercise tolerance and cardiac function via mitochondrial function. Therefore, it is necessary to clarify the pathological significance of iron in acute HF, irrespective of concomitant anemia. We investigated the impact of serum iron level at discharge on the prognosis of 615 patients emergently admitted with acute decompensated HF (ADHF). Patients were divided into two groups according to the median level of serum iron (62 µg/dL). The endpoint was the composite outcome, which included all-cause mortality and readmission for HF. During the mean follow-up period of 32.1 months, there were 333 events. Kaplan–Meier analysis showed that the incidence of the composite outcome was significantly higher in the Low iron group (P < 0.0001). In the multivariate analysis adjusted with factors including hemoglobin and ferritin levels, low serum iron was an independent predictor for the composite outcome (hazard ratio, 1.500; 95% confidence interval, 1.128–1.976; P = 0.0044). Low serum iron was an independent predictor of poor prognosis in ADHF, irrespective of hemoglobin or ferritin level, providing a new concept that iron may play a role in the pathophysiology of ADHF via non-hematopoietic roles.Tomoya UedaRika KawakamiKazutaka NogiMaki NogiSatomi IshiharaYasuki NakadaTomoya NakanoYukihiro HashimotoHitoshi NakagawaTaku NishidaKenji OnoueTsunenari SoedaSatoshi OkayamaMakoto WatanabeYoshihiko SaitoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tomoya Ueda
Rika Kawakami
Kazutaka Nogi
Maki Nogi
Satomi Ishihara
Yasuki Nakada
Tomoya Nakano
Yukihiro Hashimoto
Hitoshi Nakagawa
Taku Nishida
Kenji Onoue
Tsunenari Soeda
Satoshi Okayama
Makoto Watanabe
Yoshihiko Saito
Serum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure
description Abstract Iron is an essential trace element in the body. However, in heart failure (HF), iron is only recognized as the cause of anemia. Actually, iron itself affects myocardial exercise tolerance and cardiac function via mitochondrial function. Therefore, it is necessary to clarify the pathological significance of iron in acute HF, irrespective of concomitant anemia. We investigated the impact of serum iron level at discharge on the prognosis of 615 patients emergently admitted with acute decompensated HF (ADHF). Patients were divided into two groups according to the median level of serum iron (62 µg/dL). The endpoint was the composite outcome, which included all-cause mortality and readmission for HF. During the mean follow-up period of 32.1 months, there were 333 events. Kaplan–Meier analysis showed that the incidence of the composite outcome was significantly higher in the Low iron group (P < 0.0001). In the multivariate analysis adjusted with factors including hemoglobin and ferritin levels, low serum iron was an independent predictor for the composite outcome (hazard ratio, 1.500; 95% confidence interval, 1.128–1.976; P = 0.0044). Low serum iron was an independent predictor of poor prognosis in ADHF, irrespective of hemoglobin or ferritin level, providing a new concept that iron may play a role in the pathophysiology of ADHF via non-hematopoietic roles.
format article
author Tomoya Ueda
Rika Kawakami
Kazutaka Nogi
Maki Nogi
Satomi Ishihara
Yasuki Nakada
Tomoya Nakano
Yukihiro Hashimoto
Hitoshi Nakagawa
Taku Nishida
Kenji Onoue
Tsunenari Soeda
Satoshi Okayama
Makoto Watanabe
Yoshihiko Saito
author_facet Tomoya Ueda
Rika Kawakami
Kazutaka Nogi
Maki Nogi
Satomi Ishihara
Yasuki Nakada
Tomoya Nakano
Yukihiro Hashimoto
Hitoshi Nakagawa
Taku Nishida
Kenji Onoue
Tsunenari Soeda
Satoshi Okayama
Makoto Watanabe
Yoshihiko Saito
author_sort Tomoya Ueda
title Serum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure
title_short Serum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure
title_full Serum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure
title_fullStr Serum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure
title_full_unstemmed Serum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure
title_sort serum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/8d103a2884c24708ac5c30d0291e5d99
work_keys_str_mv AT tomoyaueda serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT rikakawakami serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT kazutakanogi serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT makinogi serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT satomiishihara serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT yasukinakada serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT tomoyanakano serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT yukihirohashimoto serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT hitoshinakagawa serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT takunishida serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT kenjionoue serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT tsunenarisoeda serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT satoshiokayama serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT makotowatanabe serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
AT yoshihikosaito serumironanewpredictorofadverseoutcomesindependentlyfromserumhemoglobinlevelsinpatientswithacutedecompensatedheartfailure
_version_ 1718392272183099392